Cardinal Health Inc logo

Cardinal Health Inc(CAH)

upturn advisory logo
EXPLORE ADVISORIES AND THEIR HISTORY
QUALITY SIGNAL RECENCY
5-STAR RATING
STRONG BUY
BUY for 25 days
PROFIT SINCE LAST BUY
+9.7% ▲
LAST CLOSE
$278.32
11/18/2026
(24-hour delay)

Advisory History & Simulated Performance *

*as per simulation (see disclosures)
  • ALL
  • 1Y
  • 1M
  • 1W
  • BUY Advisory
  • SELL Advisory (Profit)
  • SELL Advisory (Loss)
  • Profit
  • Loss
  • PASS (Skip)
Upturn Stock price based on last close iconStock price based on last close
Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Advisory Performance History (Simulated)Advisory Performance History info

Simulated performance—not actual client returns. Excludes advisory subscription fees, trading commissions, and taxes, which would reduce returns. Results depend on calculation assumptions and do not guarantee future outcomes. See Disclosures for full methodology, assumptions, and limitations.

Upturn Advisory & Investor View for CAH

11/18/2026: CAH (5-star) is a STRONG-BUY. BUY for 25 days. Simulated Profits (9.70%). Updated daily EoD!

Cardinal Health Inc is a prominent healthcare services and products company operating as a core distributor of pharmaceuticals and medical supplies. The company benefits from a resilient business model, entrenched customer relationships, and a vital position within the US healthcare supply chain, though it operates on traditionally thin distribution margins. Its primary investment story centers on steady cash flow generation, operational turnarounds in the medical segment, and expansion into high-growth specialty therapeutics. Key risks include intense oligopolistic competition, potential drug pricing reform, and cost pressures in healthcare logistics. The stock suits defensive income and value investors monitoring ongoing margin execution and specialty growth catalysts.

How to Read the Upturn Advisory

The Upturn Star Rating and the current BUY, SELL, or PASS advisory are generated by Upturn’s AI advisory engine based on proprietary signal analysis, price behavior, advisory history, and historical signal performance.

Company fundamentals, valuation, risks, and news provide supporting context about the business.

Investor Fit

Investor styleFitWhy
Growth investorMixed fitCardinal Health offers steady, predictable growth rather than rapid expansion.
Momentum investorStrong fit while signal remains positiveMomentum fit is conditional on positive price trends and a strong technical breakout signal.
Value investorStrong fitThe stock frequently trades at reasonable valuation multiples relative to its stable cash flows.
Dividend investorStrong fitThe company has a reliable history of consistent dividend payments and shareholder return commitments.
Low-risk investorStrong fitDefensive healthcare demand profile provides lower relative volatility compared to cyclical sectors.

Risk Profile

Risk factorLevelWhy it matters
Price volatilityLowAs a defensive healthcare distributor, the stock generally experiences lower volatility than broader market indices.
Valuation riskLowModest valuation multiples limit downside risk from multiple contraction.
Competition risk (oligopoly distribution market)MediumIntense competition with McKesson and Cencora keeps pressure on distribution contract renewals and margins.
Business qualityStrongEssential role in the healthcare supply chain underpins durable operational franchise quality.
Dividend incomeMediumProvides steady cash returns, though dividend growth rates are generally conservative.
Execution riskMediumMargin recovery in the medical segment and management of complex logistics networks require ongoing operational discipline.

Key Highlights

Company Size Large-Cap Stock
Market Capitalization 64.54B USD
Price to earnings Ratio 36.13
1Y Target Price 300.8
Price to earnings Ratio 36.13
1Y Target Price 300.8
Volume (30-day avg) 1.7M shares
Beta 0.52
52 Weeks Range 179.64 - 286.29
Updated Date 11/18/2026
52 Weeks Range 179.64 - 286.29
Updated Date 11/18/2026
Dividends yield (FY) 0.72%
Basic EPS (TTM) 7.73

Sector & Industry Intelligence

Sector

Healthcare

Constructive
Sentiment
Strong Bullish
Momentum
BUY Breadth Improving
BUY participation
62.3%
Active BUY / eligible
66 / 106
30-Day BUY Count Change
+23
Market state
Strong Bullish

More qualifying stocks are receiving or maintaining BUY advisories, indicating improving market participation.

Industry

Medical Distribution

BUY participation
100.0%
Active BUY / eligible
3 / 3
30-Day BUY Count Change
0

Eligible universe: 3 stocks.

Sector signal summarizes BUY breadth conditions for the sector. It does not override this stock’s BUY, SELL, or PASS advisory.

Price Behavior

Strong Uptrend
PRICE PATH

Strong Uptrend

The stock has maintained a strong upward price trend across the last three quarters.

Smooth
PRICE STABILITY

Smooth

The stock has moved along a generally orderly path with only modest fluctuations.

Analysis of Past Performance

Type Stock
Historic Profit 92.69%
Avg. Invested days 53
Today’s Advisory Strong Buy
Upturn Advisory Rating upturn star rating icon
Upturn Advisory Performance Upturn Advisory Performance icon 4.0
Stock Returns Performance Upturn Returns Performance icon 4.0
Upturn Profits based on simulation icon Profits based on simulation
Upturn last close icon Last Close 11/18/2026

Upturn Scorecard

Upturn Star Rating

★★★★★
CAH receives a 3-star rating, supported by solid quantitative characteristics, and solid analyst coverage. The rating is constrained by soft unit economics, weak price momentum, and limited analyst upside.

Company Fundamentals

★★★★★
CAH has moderate overall fundamentals (3 stars), with moderate financial health, solid growth momentum, and solid ownership. In FY2026 versus FY2025, moderate earnings growth (+9.8%) and solid revenue growth (+14.2%) are partially offset by soft cash generation (FCF margin 1.8%), soft profitability (net margin 0.7%), very low insider ownership of 0.32%.

Financial Health Rating

★★★★★
CAH's financial health is supported by strong cash strength, including free-cash-flow generation of $4.5B (1.8% of revenue). Profitability is soft (2 stars), which helps explain the 3-star overall score.

Growth Momentum Score

★★★★★
Free-cash-flow growth is CAH's strongest growth driver at +144.6% FY2026 versus FY2025 (strong, 5 stars). By comparison, revenue growth (+14.2%, solid) is also solid, while earnings growth (+9.8%, moderate) holds the profile back, so recent growth is not broad-based across the business.

Ownership

★★★★★
Institutional ownership is 90.4% and approximately 99.8% of outstanding shares are publicly tradable, supporting liquidity and institutional participation. Insider ownership is only 0.32%, which materially reduces the ownership score.

Top 5 Institutional Investors

BlackRock Inc 11.46%
Vanguard Capital Management, LLC 6.62%
Wellington Management Company LLP 6.43%
Vanguard Portfolio Management, LLC 5.94%
State Street Corp 5.18%

Unit Economics (Per $1K Revenue)

★★★★★
CAH generates approximately $38 of gross profit, $10 of operating income, and $18 of free cash flow for every $1,000 of revenue. Based on FY2026 results. Weak margins explain the 2-star rating, with moderate cash conversion and strong capital efficiency.

Economic Dimensions

★★★★★
Effective Tax Rate: 21.57%

Quantitative Style Profile

★★★★★
CAH has a large-cap, liquid, relatively low-volatility profile. Weak momentum is the primary drawback, while valuation that is moderately attractive rather than deeply discounted.

Style Classification

Quality Focused

Low VolatilityLarge / Mega Cap StabilityHighly Liquid / Institution-Friendly

How Company Makes Money

Business areaWhat it includesRetail investor read
Pharmaceutical DistributionWholesale distribution of brand, generic, and specialty prescription drugs to hospitals, retail chains, and independent pharmacies.This is the primary revenue engine, generating massive sales volume but operating on very thin profit margins.
Medical ProductsManufacture and distribution of Cardinal Health brand medical and surgical supplies, laboratory products, and procedural solutions.Provides product-level diversification and higher potential margin contributions compared to pure pharmaceutical distribution.
Pharmaceutical Solutions and Nuclear PharmacySpecialty pharmacy logistics, data solutions, and the preparation and delivery of radiopharmaceuticals.Serves as a high-value, specialized niche segment that supports overall profitability and market differentiation.

Analyzing Revenue: Products, Geography and Growth

Revenue by Products

Product revenue - Year on Year

Revenue by Geography

Geography revenue - Year on Year

Earnings Date

Report Date 2026-11-05
When Before Market
Estimate 2.92
Actual 3.26

Profitability

Profit Margin 0.7%
Operating Margin (TTM) 1.33%

Management Effectiveness

Return on Assets (TTM) 3.72%
Return on Equity (TTM) -

Valuation

Trailing PE 36.13
Forward PE 21.93
Enterprise Value 69.16B
Price to Sales(TTM) 0.25
Enterprise Value 69.16B
Price to Sales(TTM) 0.25
Enterprise Value to Revenue 0.27
Enterprise Value to EBITDA 19.35
Shares Outstanding 231.14M
Shares Floating 230.70M
Shares Outstanding 231.14M
Shares Floating 230.70M
Percent Insiders 0.32
Percent Institutions 90.37

Financial Metrics

🧭 Investment Snapshot

Total Revenue (Scale)

Information icon Total money earned from selling products or services before any costs. It is needed to understand the scale of the business and its ability to generate income.

Net Income (Profit)

Information icon Final profit after all expenses, interest, and taxes are deducted. It is needed to determine the overall profitability available to shareholders.

Free Cash Flow (Cash Strength)

Information icon Cash remaining after operating activities and capital expenditures, showing cash available for growth. It is needed to evaluate the company’s ability to invest, pay dividends, or reduce debt.

📈 Growth & Strength

Operating Income (Core Profit)

Information icon Profit from core operations after deducting all operating expenses. It is needed to measure how efficiently the company runs its primary business activities.

EBITDA (Cash Earnings)

Information icon Earnings before interest, taxes, depreciation, and amortization, indicating operating cash potential. It is needed to compare operating performance across companies without accounting or financing differences.

Gross Profit (Unit Profitability)

Information icon Revenue minus cost of revenue, showing profit after direct production costs. It is needed to evaluate core business profitability before overhead expenses.

🛡️ Financial Safety

Cash (Liquidity Buffer)

Information icon Total cash and cash equivalents on hand. It is needed to evaluate immediate liquidity and financial flexibility.

Total Debt (Leverage Risk)

Information icon Total debt including both short-term and long-term components. It is needed to assess the company’s leverage and financial risk.

Net Working Capital (Short-Term Health)

Information icon Current assets minus current liabilities, indicating short-term liquidity strength. It is needed to assess whether the company can meet its short-term obligations.

🧱 Balance Sheet Strength

Stockholder Equity (Net Worth)

Information icon Total equity value held by shareholders. It is needed to understand the net worth of the company from the owners’ perspective.

Total Assets (Asset Base)

Information icon The full value of everything the company owns, including cash, inventory, equipment, and investments. It is needed to understand the resource base used to generate revenue.

Income Before Tax (Pre-Tax Earnings)

Information icon Income before provision for income taxes. It is needed to analyze profitability independent of tax structures.

⚙️ Cost & Drag Factors

Cost of Revenue (Production Cost)

Information icon Direct costs required to produce and deliver the products or services sold. It is needed to assess efficiency in production and service delivery.

Total Operating Expenses (Operating Cost)

Information icon Indirect costs of running the business such as salaries, marketing, and administration. It is needed to understand how much it costs to sustain ongoing business operations.

Income Tax Expense (Tax Drag)

Information icon Amount of taxes paid or payable to the government. It is needed to evaluate the impact of taxation on overall profitability.

Form CRS provides a relationship summary of our automated advisory services, flat subscription fees, and conflicts of interest. Form ADV Part 2A brochure contains complete details on services, billing, and disclosures. If any summary differs from our current regulatory filings, the filed Form ADV controls.